Pharming Group N.V.
PHAR
$8.51
-$0.07-0.82%
NASDAQ
| 12/31/2023 | 12/31/2023 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Net Income | -190.16% | -190.16% | 162.62% | ||
| Total Depreciation and Amortization | -39.52% | -39.52% | -8.22% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 679.42% | 679.42% | 111.28% | ||
| Change in Net Operating Assets | 69.68% | 69.68% | -481.92% | ||
| Cash from Operations | 228.24% | 228.24% | 136.66% | ||
| Capital Expenditure | -106.80% | -106.80% | 80.93% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 93.79% | 93.79% | 12.35% | ||
| Cash from Investing | 93.29% | 93.29% | 13.14% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -27.01% | 81.03% | 19.95% | ||
| Issuance of Common Stock | -97.04% | -97.04% | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 100.26% | 52.94% | -240.09% | ||
| Cash from Financing | -119.47% | -119.47% | 299.32% | ||
| Foreign Exchange rate Adjustments | 148.08% | 148.08% | -95.50% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 114.07% | 114.07% | 36.84% | ||